肌萎缩侧索硬化
医学
疾病
神经学
临床试验
SOD1
重症监护医学
生物信息学
病理
精神科
生物
出处
期刊:Continuum
[Ovid Technologies (Wolters Kluwer)]
日期:2023-10-01
卷期号:29 (5): 1538-1563
被引量:13
标识
DOI:10.1212/con.0000000000001345
摘要
There has been continued progress in ALS genetics, diagnosis, and disease-modifying therapies. However, we still lack a definitive biomarker or a treatment that can halt the progression or reverse the course of disease. The evolving understanding of the genetic and pathophysiologic underpinnings of disease offers promise for more effective and clinically meaningful treatments in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI